CIK 0001425205 · Accelerated filer
IOVANCE BIOTHERAPEUTICS, INC.
Sign in to watch- Ticker
- IOVA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 753254381
- Phone
- 6502607120
- Business address
- 825 INDUSTRIAL ROAD, 4TH FLOOR, SAN CARLOS, CA, 94070
- Former names
- Lion Biotechnologies, Inc., Genesis Biopharma, Inc, FREIGHT MANAGEMENT CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-01 | BILINSKY IGOR Chief Operating Officer | Shares withheld for taxes | −4,464 | $2.23 | $10K | 104,014 |
| 2025-12-01 | BILINSKY IGOR Chief Operating Officer | Option exercise · Restricted Stock Units | −8,789 | 43,949 | ||
| 2025-12-01 | Vogt Frederick G Interim CEO & General Counsel | Option exercise | +41,669 | 476,232 | ||
| 2025-12-01 | Vogt Frederick G Interim CEO & General Counsel | Shares withheld for taxes | −17,701 | $2.23 | $39K | 458,531 |
| 2025-12-01 | Vogt Frederick G Interim CEO & General Counsel | Option exercise · Restricted Stock Units | −41,669 | 208,344 | ||
| 2025-12-01 | Puri Raj K. Chief Regulatory Officer | Option exercise | +5,469 | 218,326 | ||
| 2025-12-01 | Puri Raj K. Chief Regulatory Officer | Shares withheld for taxes | −2,467 | $2.23 | $6K | 215,859 |
| 2025-12-01 | Puri Raj K. Chief Regulatory Officer | Option exercise · Restricted Stock Units | −5,469 | 27,348 | ||
| 2025-09-02 | Vogt Frederick G Interim CEO & General Counsel | Option exercise | +52,086 | 456,690 | ||
| 2025-09-02 | Vogt Frederick G Interim CEO & General Counsel | Shares withheld for taxes | −22,127 | $2.19 | $48K | 434,563 |
| 2025-09-02 | Vogt Frederick G Interim CEO & General Counsel | Option exercise · Restricted Stock Units | −10,417 | 20,385 | ||
| 2025-09-02 | Vogt Frederick G Interim CEO & General Counsel | Option exercise · Restricted Stock Units | −41,669 | 250,013 | ||
| 2025-09-02 | Puri Raj K. Chief Regulatory Officer | Option exercise | +5,470 | 215,324 | ||
| 2025-09-02 | Puri Raj K. Chief Regulatory Officer | Shares withheld for taxes | −2,467 | $2.19 | $5K | 212,857 |
| 2025-09-02 | Puri Raj K. Chief Regulatory Officer | Option exercise · Restricted Stock Units | −5,470 | 32,817 | ||
| 2025-09-02 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Option exercise | +12,697 | 111,857 | ||
| 2025-09-02 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Shares withheld for taxes | −6,448 | $2.19 | $14K | 105,409 |
| 2025-09-02 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Option exercise · Restricted Stock Units | −3,907 | 7,813 | ||
| 2025-09-02 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Option exercise · Restricted Stock Units | −8,790 | 52,738 | ||
| 2025-09-02 | BILINSKY IGOR Chief Operating Officer | Option exercise | +12,306 | 105,939 |
Page 7 of 14 · 280 trades